$11.94
-0.49-3.94%
At close: -
$11.80
-0.14-1.17%
After Hours: 6:11 PM EDT
AngioDynamics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AngioDynamics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q2 | 2025-01-08 | $-0.04 | $-0.11 | 63.6 % |
Q1 | 2024-10-03 | $-0.11 | $-0.15 | 26.7 % |
Q4 | 2024-07-16 | $-0.06 | $-0.16 | 62.5 % |
Q3 | 2024-04-04 | $-0.16 | $-0.13 | -23.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2025-01-08 | $72.85M | $70.93M | 2.70 % |
Q1 | 2024-10-03 | $67.49M | $67.93M | -0.65 % |
Q4 | 2024-07-16 | $70.98M | $70.89M | 0.13 % |
Q3 | 2024-04-04 | $75.18M | $75.73M | -0.72 % |
AngioDynamics (ANGO) is scheduled to report earnings on April 3, 2025. The last reported earnings were for reported on January 8, 2025 for Q2.
The Actual EPS was $-0.04, which beat the estimate of $-0.11.
The Actual Revenue was $72.8M, which beat the estimate of $70.9M.
Browse earnings estimates, EPS, and revenue on all stocks.